US › Healthcare

Decoy Therapeutics Inc. (DCOY)

US · Healthcare · Biotechnology

$4.37+0.69%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

Net profit

$-2.2M

Profit YoY

-30.1%

EPS

$-4.18

EPS estimate

$-4.08

EPS came in at -4.18 against a street estimate of -4.08 — a miss of 2.5%.

Key statistics

Market cap

$2.2M

P/E

0.0

Forward P/E

0.0

P/B

0.57

Book value

$7.29

EPS (TTM)

$107.05

52-week high

$113.40

52-week low

$3.51

50-day MA

$6.23

200-day MA

$11.23

Beta

0.59

Analyst view

with an average price target of $30.00.

Shareholding

Insiders

0.58%

Institutions

12.16%

Largest institutional holders

Fund	Stake
Tower Research Capital LLC	0.19%
UBS Group AG	0.10%
Advisory Services Network, LLC	0.01%
Morgan Stanley - Brokerage Accounts	0.00%
Danske Bank A/S.	0.00%
Warberg Asset Management LLC	0.00%
Geode Capital Management, LLC	0.00%
Advisor Group Holdings, Inc.	0.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Decoy Therapeutics Inc. — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.